IM Cannabis Corp. (IMCC), a specialty drug manufacturer focused on cannabis products, faces significant Shariah compliance challenges primarily due to its high debt levels and involvement in recreational cannabis, which is widely viewed as non-permissible. Financial ratios indicate failure on debt thresholds across all standards, while liquidity and income ratios are compliant. Business activity screening highlights recreational sales as disqualifying. No inclusion in major Shariah indices confirms non-compliance status. Investors should consider purification for incidental income and monitor potential shifts to purely medical operations.